PMID- 28485899 OWN - NLM STAT- MEDLINE DCOM- 20180515 LR - 20180816 IS - 1530-0277 (Electronic) IS - 0145-6008 (Linking) VI - 41 IP - 7 DP - 2017 Jul TI - Determinants of Blood Brain-Derived Neurotrophic Factor Blood Levels in Patients with Alcohol Use Disorder. PG - 1280-1287 LID - 10.1111/acer.13414 [doi] AB - BACKGROUND: Blood brain-derived neurotrophic factor (BDNF) levels are influenced by both addiction and mood disorders, as well as somatic conditions, gender, and genetic polymorphisms, leading to widely varying results. Depressive symptoms and episodes are frequently observed in patients with alcohol use disorder, and vary widely over time, making it a challenge to determine which aspects are specifically involved in variations of serum BDNF levels in this population. METHODS: We assessed 227 patients with alcohol dependence involved in a detoxification program, at baseline and after a follow-up of 6 months, for the Alcohol Use Disorders Identification Test score, the length of alcohol dependence, and the number of past detoxification programs. The Beck Depression Inventory and information on current tobacco and alcohol use, suicidal ideation, body mass index, age, gender, and psychotropic treatments were also collected. Serum BDNF (ELISA) and 2 genetic polymorphisms of the BDNF gene (Val33Met and rs962369) were analyzed. RESULTS: The presence of the Met allele, 2 markers of the history of alcohol dependence (gamma glutamyl transferase and the number of past treatments in detoxification programs), and the presence of a depressive episode (but not depressive score) were significantly associated with the 2 blood levels of BDNF at baseline and after 6 months. After controlling for baseline BDNF levels, the presence of the Met allele and an ongoing depressive episode were the only variables associated with changes in BNDF levels after 6 months. CONCLUSIONS: Low serum BDNF levels are associated with characteristics related to alcohol consumption and mood disorders, and variants of the BDNF gene in alcohol use disorder patients. The factors that most strongly influenced changes in serum BDNF levels following treatment in an alcohol detoxification program were variants of the BDNF gene and ongoing depression. CI - Copyright (c) 2017 by the Research Society on Alcoholism. FAU - Nubukpo, Philippe AU - Nubukpo P AD - Pole d'Addictologie, Centre Hospitalier Esquirol, Limoges, France. AD - Unite de Recherche et de Neurostimulation, Centre Hospitalier Esquirol, Limoges, France. FAU - Ramoz, Nicolas AU - Ramoz N AD - Inserm UMR894, Centre de Psychiatrie et Neurosciences, Paris, France. FAU - Girard, Murielle AU - Girard M AUID- ORCID: 0000-0003-1222-0329 AD - Unite de Recherche et de Neurostimulation, Centre Hospitalier Esquirol, Limoges, France. FAU - Malauzat, Dominique AU - Malauzat D AD - Unite de Recherche et de Neurostimulation, Centre Hospitalier Esquirol, Limoges, France. FAU - Gorwood, Philip AU - Gorwood P AD - Inserm UMR894, Centre de Psychiatrie et Neurosciences, Paris, France. AD - Clinique des Maladies Mentales et de l'Encephale (CMME), Hopital Sainte-Anne, Universite Paris Descartes, Paris Cedex, France. LA - eng PT - Journal Article DEP - 20170530 PL - England TA - Alcohol Clin Exp Res JT - Alcoholism, clinical and experimental research JID - 7707242 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Adult MH - Alcoholism/*blood/genetics/psychology/therapy MH - Brain-Derived Neurotrophic Factor/*blood/genetics MH - Cohort Studies MH - Depressive Disorder/*complications MH - Female MH - Humans MH - Male MH - Middle Aged OTO - NOTNLM OT - Alcohol OT - Brain-Derived Neurotrophic Factor OT - Depression OT - Withdrawal EDAT- 2017/05/10 06:00 MHDA- 2018/05/16 06:00 CRDT- 2017/05/10 06:00 PHST- 2017/01/17 00:00 [received] PHST- 2017/05/02 00:00 [accepted] PHST- 2017/05/10 06:00 [pubmed] PHST- 2018/05/16 06:00 [medline] PHST- 2017/05/10 06:00 [entrez] AID - 10.1111/acer.13414 [doi] PST - ppublish SO - Alcohol Clin Exp Res. 2017 Jul;41(7):1280-1287. doi: 10.1111/acer.13414. Epub 2017 May 30.